HeadlinesBriefing favicon HeadlinesBriefing

Private Equity 3 Hours

×
2 articles summarized · Last updated: LATEST

Last updated: June 12, 2026, 5:30 AM ET

Private‑Equity Deal Flow

A Series A round for dermatologist‑born Remedy Science saw L Catterton lead the funding, valuing the brand at an undisclosed multiple as investors chase the clinically‑backed beauty niche. Meanwhile, Astorg‑backed IPCOM signals intent to acquire a majority stake in Le Froid Pecomark, underscoring a broader shift toward industrials where high revenues and long‑term growth prospects lure private‑equity capital. Both moves highlight a widening appetite for sectors that combine strong cash flows with scalable, technology‑driven operations.